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Abstract 
In patients with cardiac failure, bioreactance based cardiac output (CO) monitoring provides 
a valid non-invasive method for assessing cardiac performance during exercise. The purpose 
of this study was to evaluate the efficacy of this technique during strenuous exercise in 
healthy, trained individuals. Fourteen recreational cyclists, mean (SD) age 34 (8) years and 
relative peak oxygen uptake (VO2) 56 (6) ml•kg-1•min-1, underwent incremental maximal 
exercise testing, whilst CO was recorded continuously using a novel bioreactance based 
device (CObio). The CObio was evaluated against relationship with VO2, theoretical 
calculation of arterial venous oxygen difference (C(a-v) O2) and level of agreement with an 
inert gas rebreathing method (COrb) using a Bland-Altman plot. Bioreactance based CO 
measurement was practical and straightforward in application, although there was 
intermittent loss of electrocardiograph signal at high intensity exercise. At rest and during 
exercise, CObio was strongly correlated with VO2 (r=0.84; P < 0.001), however there was 
evidence of systematic bias with CObio providing lower values than COrb; mean bias (limits 
of agreement) -19 % (14.6 to –53 %). Likewise, calculated (C(a-v) O2) was greater when 
determined using CObio than COrb (P<0.001), although both devices provided values in 
excess of those reported in invasive studies. Bioreactance based determination of CO 
provides a pragmatic approach to the continuous assessment of cardiac performance during 
strenuous exercise in trained individuals. Our findings however suggest that further work is 
needed to refine the key measurement determinants of CO using this device to improve 
measurement accuracy in this setting. 
Key words: rebreathing methods, exercise testing, oxygen uptake, exercise hemodynamics 
3 
 
Introduction 
Measurement of cardiac output (CO) during exercise provides a valuable insight into the 
cardiovascular response to physiological stress and is an important component in assessing the 
integrative cardiorespiratory response. Several methods have been employed to evaluate CO 
during exercise (for review see Warburton et al., 1999a; Warburton et al., 1999b). Invasive 
techniques, dependent upon vascular catheterisation and direct Fick calculation are generally 
regarded as the ‘gold standard’ (Warburton et al., 1999a), however the practical utility of these 
techniques is limited by the fact that they are expensive, require specialist expertise and are 
associated with inherent risks (e.g. vascular occlusion) (Scheer et al., 2002). 
A number of non-invasive techniques have therefore been evaluated in this setting and 
include methods employing gas rebreathing (Jakovljevic et al., 2008), the modelflow method 
(Sugawara et al., 2003) and bioimpedance cardiography (Richard et al., 2001). The latter is based 
upon the principle that assessment of electrical conductance properties across the thorax can be 
used to calculate aortic blood flow (Kubicek et al., 1966). This technique is advantageous in the 
exercise setting given it is easy to apply, versatile and permits continuous monitoring of cardiac 
function (Richard et al., 2001; Warburton et al., 1999b). Bioimpedance CO has been compared 
with invasive methodologies at rest (Miles & Gotshall, 1989) and during exercise (Teo et al., 
1985) with conflicting reports of accuracy (Warburton et al., 1999b; Smith et al., 1988). Some of 
the discrepancy reported may arise from difficulty in obtaining signals sufficiently free of noise 
artefact and a need to precisely model thoracic dimensions and distance between electrode 
placements (Denniston et al., 1976; Warburton et al., 1999b). 
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A  novel bioreactance based device, the NICOM (Cheetah Medical, Delaware, USA), has 
become available (Keren et al., 2007) offering the potential to address these deficiencies. In 
contrast to the amplitude based calculation of bioimpedance, bioreactance provides CO data 
from analysis of the frequency of relative phase shifts of electrical current injected across the 
thorax and as such is less subject to interference. It has been argued that this device yields a 
signal-to-noise ratio that is about 100-fold greater than bioimpedance (Squara et al., 2007). 
Furthermore it is reported that signal magnitude is not affected by precision of electrode 
placement, body movement or respiratory excursion (Keren et al., 2007).  
The NICOM bioreactance device has been found to have good precision in comparison 
with invasive methods at rest and in response to physiological challenge (e.g. fluid loading) 
(Keren et al., 2007). In addition, Myers et al. (2007, 2009) recently reported good face validity of 
the bioreactance method during exercise as evidenced by a strong relationship between NICOM 
determined CO (CObio) and oxygen uptake (VO2) in patients referred with cardiac failure. In this 
setting the device was reported to be easy to use and provided consistent and valid results. 
However, the NICOM device has not been evaluated during strenuous exercise in trained 
individuals.   
The aim of this study was therefore to extend previous application of this device by 
evaluating the practicality and utility of the NICOM bioreactance device for measuring CObio 
during cycle ergometry at different exercise intensities in trained young individuals. In addition 
we assessed level of agreement between the NICOM device and contemporaneous measures 
taken from an alternative non-invasive CO monitoring device; based upon principles of inert gas 
rebreathing (Innocor, Innovision, Denmark) (COrb). This device has previously been validated 
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against invasive techniques and been found to produce accurate, reproducible CO data during 
maximal cycle ergometry exercise (Jakovljevic et al., 2008). 
Methods 
Subjects  
Fourteen healthy male recreationally trained cyclists (age 34 ± 8 years, body mass 80.5 ± 
8.4 Kg, height 1.81 ± 0.4 m, VO2peak 56.1 ± 5.7 ml•kg-1•m-1) were recruited to participate in the 
study Subjects provided written informed consent and the study was approved by the Kingston 
University Ethics Committee. All procedures were in accordance with the Declaration of 
Helsinki. Subjects with a history of cardiac or respiratory disease were excluded. 
Study Design  
Subjects were requested to attend on one occasion to perform an incremental maximal 
exercise test on an electromagnetically-braked cadence independent cycle ergometer (Velotron, 
Racermate Inc., USA). They abstained from exercise in the 24 hours preceding exercise and 
from caffeinated beverages, alcohol and tobacco on the day of assessment. Following 
determination of height, weight and calculation of body mass index (BMI) (kg/m2), subjects 
were familiarised with the exercise equipment and protocol.  
Exercise protocol  
After baseline resting measurement of CO (detailed below) subjects commenced cycling 
at 150 W for five minutes followed by 200 W for a further five minutes. Power output was then 
incremented by 30 W every three minutes until exhaustion (Figure 1). Active encouragement 
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was given at all times throughout the test to encourage maximal volitional effort. Exercise was 
terminated at volitional exhaustion with the test duration ranging from 16 to 28 mins, depending 
on the physical condition of the individual.. Subjects used their own cycling shoes and were 
permitted to self-select their cadence throughout the exercise protocol. 
Throughout the exercise period breath-by-breath gas exchange data were collected 
continuously using an online system (Innocor, Innovision, Denmark) and averaged over 30 s 
epochs. Heart rate (HR) was recorded continuously using a telemetric monitor (Polar S610, Polar 
Elecktro, Finland).  
Cardiac output measurements 
At rest, CO was determined as the mean of triplicate values obtained over a period of 5 
min rest whilst seated on the ergometer. During exercise, CObio was measured continuously with 
values recorded during the final minute of each exercise stage. The COrb was measured at two 
timepoints; during the final minute of the 200 W stage and in the final exercise stage when 
subjects indicated they were near to exhaustion but still remained able to comply with the 
rebreathing protocol (Figure 1). Cardiac index (CI) is reported as CO / body surface area 
(Mosteller, 1987). 
Bioreactance cardiac output (CObio) 
The CObio (NICOM, Cheetah Medical, Delaware, USA) was determined as described 
elsewhere (Myers et al., 2009). In brief, blood flow within the aorta was calculated based on an 
assessment of the phase shifts in an alternating radiofrequency electrical current (dΦ/dtmax) 
measured across the thorax. CO was subsequently determined from: 
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CO = (C * VET *dΦ/dtmax) * HR  [1] 
where C is a constant of proportionality (based upon subject age, gender and body size) and VET 
is ventricular ejection time determined from the NICOM and electrocardiograph signal.  
Two surface dual-electrodes were applied over the trapezius muscle on either side of the 
upper torso and two on the lower posterior torso lateral to the margin of the latissimus dorsi 
musculature. Electrode connections were secured with medical tape and all connecting wires 
supported to ensure minimal movement artefact. The system was then auto-calibrated and an 
adequate electrocardiograph signal and NICOM waveform was established prior to the 
acquisition of data.  
Innocor rebreathing cardiac output (COrb) 
The COrb was determined using an inert gas rebreathing technique (Innocor, Innovision, 
Denmark). The system consists of a three-way respiratory valve with a mouthpiece and a 
rebreathing bag connected to a photoacoustic analyser. The device requires subjects to inhale an 
inert gas mixture; consisting of 0.5 % nitrous oxide (N2O); 0.1 % sulphur hexafluoride; (SF6) and 
a 28 % O2 in nitrogen mixture in a closed system (i.e. with a nose clip in situ). In order to take a 
measurement subjects perform a specific rebreathing manoeuvre over a 30 s period during which 
subjects are required to completely empty the rebreathing bag with each inspiration. The 
software then determined CO based upon the rate of decrease in the concentration of N2O during 
the manoeuvre. The COrb was taken as proportional to pulmonary blood flow with the 
assumption of an insignificant intra-pulmonary shunt.  
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Arterial-venous oxygen difference  
The arterial-venous oxygen difference (C(a-v) O2) was calculated using a re-arrangement 
of the direct Fick equation (16): 
C(a-v) O2 (ml/dl) = 100 * (VO2 (l/min) / CO (l/min))  [2] 
Data analysis 
Data are expressed as mean ± SD unless otherwise stated. Pearson’s correlation 
coefficient was used to evaluate the relationship between CO
 
and VO2 measures taken at 
contemporaneous timepoints. Differences between CObio and COrb were compared using the 
method described by Bland and Altman (1986) with difference expressed as mean bias (upper 
and lower 95 % limits of agreement) and a two-sided paired t-test to determine significance. 
Intra-class correlation coefficient (ICC) was also determined. All statistical analyses were 
performed on GraphPad (Prism v. 5, GraphPad Software Inc, USA) with a P value of < 0.05 
considered significant.
 
Results 
Cardiac output data 
Rest  
In all subjects, high quality, stable NICOM waves and electrocardiograph data were 
obtained with a high mean ICC, 0.94 (P<0.001) for triplicate measures of CObio at rest. Similarly, 
all subjects were able to perform the rebreathing manoeuvre adequately. The ICC of COrb was 
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lower at 0.61 (P<0.05). Resting COrb was greater than CObio (P=0.019) with a mean bias of 1 
l/min (LOA 1.7 to -3.7 l/min) or -14.4 % (25 to -54 %) (Table 1 and Figure 2).  
Exercise 
Due to inadequate rebreathing manoeuvre we were unable to obtain a COrb reading in one 
subject at the 200 W stage and in three subjects at the maximal stage. In contrast the NICOM 
device provided data throughout exercise, with no evidence of electrode detachment. In 9 of the 
14 (65%) subjects however the electrocardiograph trace was intermittently lost during higher 
intensity exercise (HR > 160 bpm), resulting in lower values for HR from the NICOM device 
when compared with the HR monitor.  
Cardiac output 
Exercise CO data are shown in Table 1. The relationship between power output and both 
CObio and VO2 is shown in Figure 3. At maximal exercise both CObio (r=0.84, P<0.001) and COrb 
(r=0.72, P<0.001) were correlated with VO2 during exercise (Figure 4). There was an increase in 
dΦ/dtmax from rest to maximal exercise (175.2 ± 42.5 to 445.6 ± 108.5 ohm/s), with a 
concomitant decrease in VET (276 ± 26.1 to 187.2 ± 16.6 ms); stroke volume from the 
bioreactance device was 86.8 ± 14.4 ml at rest, rising to 111± 22 ml and 137± 43 ml at 200 W 
and maximal exercise, respectively. 
Comparison of methods 
The CO data from the two devices were correlated (r=0.93; P<0.001) although the 
strength of this relationship was reduced when resting data was excluded (r=0.54; P<0.01). 
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Bland-Altman plot (Figure 2) and scatterplot against line of identity (Figure 5) demonstrated a 
consistent bias in favour of greater COrb when compared with CObio. 
Discussion 
The purpose of this study was to evaluate the performance of the NICOM bioreactance 
device for determining CO at rest and during incremental exercise in healthy trained subjects. 
The device was simple to use, comfortable for subjects and provided reliable, stable bioreactance 
and electrocardiograph waveform traces at rest, with a high intra-class correlation coefficient 
between triplicate measures. Furthermore the values obtained for CO at rest using the NICOM 
device were consistent with values reported using invasive techniques in a population with 
similar characteristics (Stringer et al., 1997; Sun et al., 2000; Stickland et al., 2006).  
During exercise, however we found that whilst CObio paralleled increases in power output 
and was strongly related to VO2, the electrocardiograph signal produced at higher intensity 
exercise were less reliable with an intermittent loss of signal and a discrepancy between the HR 
values obtained from the NICOM device and contemporaneous measures from a separate 
monitoring device. This was despite meticulous preparation and fixation of electrodes (Myers et 
al., 2007). Furthermore we noted that subjects were required to maintain a relatively stable upper 
body position throughout exercise to avoid the precipitation of signal artefact.  
Comparison of CO between the bioreactance and rebreathing systems revealed 
statistically significant differences between contemporaneous values; specifically a consistent 
bias for CObio to provide lower values than COrb. The relative magnitude of this difference was 
similar at rest and during exercise. 
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In the absence of a ‘gold standard’ comparator it is difficult to ascertain which 
methodology most closely represented true exercise CO. In this context, calculation of arterial-
venous oxygen difference (C(a-v) O2) (eqn [2]) (Stringer et al., 1997), has been shown to be a 
useful surrogate indicator of the accuracy of a CO device. Invasive studies consistently 
demonstrate a progressive increase in oxygen extraction during incremental exercise proportional 
to VO2. Jakovljevic et al. (2008) used this approach to evaluate the Innocor system during 
incremental cycle exercise and found calculated C(a-v) O2 at maximal exercise (16.4 ml/dl O2) 
was consistent with that reported using invasive methods (Stringer et al., 1997). In this study the 
calculated C(a-v) O2 difference obtained using the NICOM device was 22.4 ml/dl O2 at peak 
exercise. In the presence of a normal haemoglobin (150 g/L) and arterial oxygen saturation 
(98%) this would equate to a physiologically impossible mean oxygen extraction ratio (C(a-v) O2 
/ arterial O2 content) of over 100 % (Stringer et al., 1997). Overall therefore we would expect CO 
values for this population to be greater and more in keeping with reports from invasive studies 
indicating an average CO of at least 27 l/min for a similar peak VO2 (4.4 l/min) (Teo et al., 
1985).  
The reason for this discrepancy from previously reported values at high intensity exercise 
is not immediately apparent although it is consistent with previous studies detailing a systematic 
underestimation of exercise CO with bioimpedence (Smith et al., 1988). The NICOM system 
determines CO as the product of HR, VET, dΦ/dtmax and a constant of proportionality (Eqn [1]). 
The manner in which these determinants interact to provide the final CO reading is commercially 
restricted, however the device algorithm and invasive validation assessment has been reported in 
an older untrained population (Keren et al., 2007; Myers et al., 2007; Squara, 2008). This is the 
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first time the device has been assessed in a healthy young population and our finding of 
systematic bias at rest and all exercise intensities suggests that alternative correction factors may 
be appropriate and improve measurement accuracy. The cardiovascular hemodynamic response 
to incremental exercise has been reported using invasive techniques (Stickland et al., 2006). 
Furthermore, similar studies utilising the bioreactance device (Myers et al., 2009) have only  
compared cardiac failure patients with ‘normal’ untrained subjects reporting dyspnoea of non-
cardiac origin and a limited cardiovascular and exercise reserve.  
Additional reasons for the apparent underestimation of cardiac output measurements 
include possible influence of interference / movement artefact, although in the present study we 
found adequate NICOM trace quality during exercise. The discrepancy between NICOM 
determined HR and the equivalent value from an alternative monitor at high intensity exercise 
may in at least part explain underestimation of maximal CO and is an important deficiency to be 
addressed.  
Study limitations 
In this study we did not compare the NICOM device with an invasive ‘gold standard’ method, 
which would be desirable to provide further validation data. Our selection of study design 
however was based upon a pragmatic solution to the lack of access to cardiac catheterization 
facilities and subjects willing to undergo such testing. We do not feel however that this 
influences interpretation of the study given our principle finding was of a systematic 
underestimation of CO based upon expected values from invasive studies in a population with 
similar characteristics.  The results from this study have permitted a preliminary evaluation of 
the performance of the NICOM device without exposing subjects to invasive testing. 
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In conclusion our findings suggest that whilst this device offers a simple, versatile and 
cost effective means of determining CO at rest we found limited utility during strenuous exercise 
in this population. In particular, the finding of a systemic measurement bias suggests that further 
work is needed before this device can be recommended for the assessment of exercise cardiac 
performance in healthy trained individuals.  
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Figure legends 
Figure 1 Timeline of study measurements. Arrows / connectors indicate time of measurement 
Figure 2 Bland-Altman plot comparing average of CObio and COrb at rest and during 
exercise with percentage difference between measurements (n = 13). Mean percentage 
difference (% diff) and LOA for rest and exercise combined. LOA; 95 % limit of agreement 
Figure 3 Relationship between power output, NICOM determined CO (CObio) and oxygen 
uptake (VO2) (n = 14). Values represent mean with error bars +/- 1 standard error of mean. VO2 
- - - -  CObio   
Figure 4 Relationship between cardiac output (CO) and oxygen uptake (VO2). Cobio (n = 14) 
at rest ( ) and during exercise ( ) and COrb (n = 13) at rest ( ) and during exercise ( ). Best fit 
regression lines are shown for CObio ; COrb - - - - and relationship reported by Stringer et 
al.(16). - - - - 
Figure 5 Scatterplot (n = 13) of rebreathing CO (COrb) vs bioreactance CO (CObio) at rest 
( ) and during exercise (○). CO; cardiac output. Line of identity is plotted  
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